Delivery Order HHSN261201700014I-75N91020F00004
Award Date 7/15/20
Potential Completion Date 12/31/20
Potential Value $26K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency, to SRI International, a non-profit research and development institute. The $26,166.42 contract is for the analysis of anti-cancer chemicals and pharmaceutical formulations, including tests for appearance, NMR, IR, HPLC, residual solvents, moisture, residue on ignition, and heavy metals for a specific chemical compound, NSC 706744. This contract is part of a larger $26.2 million...
- This is a $67,787,765.29 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) to SRI International, a non-profit research and development institute, for preclinical toxicology and pharmacology of drugs. The contract supports biomedical research and drug development services for the NCI. SRI International has multiple indefinite delivery vehicles (IDVs) with federal agencies like the Department of Defense, NASA, and the National Institutes of Health that enable efficient...
- This is a federal contract award from the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract, worth $21,593,775.02, is for "PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND OTHER THERAPEUTIC AGENTS" and was awarded on December 15, 2004 with a completion date of December 14, 2012. The contract type is Definitive Contract with a Cost Plus Fixed Fee pricing...
- This is a $7,910,623.00 cost-plus-fixed-fee contract awarded by the National Cancer Institute (part of the U.S. Department of Health and Human Services) to SRI International, a non-profit research and development institute. The contract is for analysis of anti-cancer chemicals and pharmaceutical formulations. It does not have a small business set-aside designation. SRI International frequently serves as a prime contractor and subcontractor on research and development contracts and grants with...
- This is a $6,179,640.00 Cost Plus Fixed Fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to SRI International, a non-profit research and development institute. The contract is for non-clinical studies in support of Investigational New Drug (IND), New Drug Application (NDA), and Biologics License Application (BLA) submissions. It has an ultimate completion date of July 20, 2027 and was awarded on September 1, 2022. The...
- This is a $237,574 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS). The contract is for the investigation and optimization of FG-960 preclinical formulations and was awarded to the non-profit research institute SRI International. The work will be performed in West Menlo Park, California. This delivery order falls under the larger...
- This is a $3,626,906.00 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to SRI International, a non-profit research and development institute. The contract is for non-clinical studies in support of Investigational New Drug (IND), New Drug Application (NDA), and Biologics License Application (BLA) submissions. The contract has a period of performance through July 20, 2027 and uses a cost-plus-fixed-fee pricing...
- This is a cost-plus-fixed-fee delivery order task order awarded by the Department of Health and Human Services' National Institute on Drug Abuse (NIDA) to nonprofit research institute SRI International. The contract, valued at $479,933.60, is for toxicological evaluations of potential medications over a period of performance from September 7, 2018 to September 6, 2023. SRI International has extensive experience providing research, engineering, and technical services to federal agencies such as...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institutes of Health (NIH), National Institute of Child Health and Human Development, to SRI International, a non-profit research institute, for BIOLOGICAL TESTING FACILITY, TASK ORDER 10: CLINICAL MANUFACTURING AND FORMULATION. The contract has a potential value of $1,869,475.56 and a completion date of September 12, 2023. SRI International has a history of providing research, development, and advisory services to...
- This is a $434,382.00 cost-plus-fixed-fee delivery order (TO 9) awarded by the National Institutes of Health (NIH) National Institute of Child Health and Human Development to SRI International, a non-profit research and development organization. The order is for a "Chemical Optimization Approaches" task as part of the broader "Chemical Screening and Optimization Facility" program, with a period of performance from September 29, 2022 to September 28, 2023. The order was not...